NCT06483542

Brief Summary

The bioenergetic balance is the sum of energy exchanged during CRRT and is mostly defined by citrate glucose and lactate. When CRRT was performed with the older dialysis fluids, glucose and lactate could be an important source of energy next to citrate when used as predilution (6, 7). During continuous venovenous hemofiltration (CVVH), a subgroup of CRRT which is performed with the newer dialysis fluids without lactate or glucose as advocated by the KDIGOguidelines, glucose and in a minor way lactate mostly induce a loss of energy. The first aim is to determine how this bioenergetic balance impacts energy need compared to the measured energy with indirect calorimetry and how nutrition therapy needs to be adapted. Also, disease specific predicting equation have been created for patients suffering from acute kidney injury treated with renal replacement therapy. How this predicting equation and other existing predicting equations agree with the measured REE has not been validated yet. The second aim is to determine how predictive equations correlate with measured REE in patients treated with CVVH.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

July 3, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

3 months

First QC Date

January 24, 2023

Last Update Submit

July 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Energy

    expressed in Kcal

    during study completion, on average 4weeks

Secondary Outcomes (2)

  • resting energy expenditure

    during study completion, on average 4weeks

  • protein to energy ratio

    during study completion, on average 4weeks

Study Arms (1)

Group 1

all patients

Other: bioenergetic balance

Interventions

Bioenergetic balance is calculated for all patients who had a resting energy expenditure measurement with indirect calorimetry.

Group 1

Eligibility Criteria

Age18 Years - 130 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult critically ill patients with acute kidney injury who require CVVH

You may qualify if:

  • Patients admitted to the adult ICU (01/01/2021-30/09/2022)
  • At least one indirect calorimetry measurement (ventilator) or calculation based on harris benedict OR 25Kcal/kg/day
  • Combined with bio energetic balance measurement
  • Receiving CVVH during intensive care stay

You may not qualify if:

  • The absence of an indirect calorimetry measurement (ventilator) or calculation - based on the Harris Benedict OR 25Kcal/kg/day formula OR The absence of a bio energetic balance measurement
  • The absence of CVVH during intensive care stay
  • Pediatric (intensive care unit) patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair ziekenhuis Brussel

Jette, Vlaams Brabant, 1090, Belgium

Location

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Joop Jonckheer, PhD

    Universitair Ziekenhuis Brussel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2023

First Posted

July 3, 2024

Study Start

February 1, 2023

Primary Completion

April 30, 2023

Study Completion

September 30, 2024

Last Updated

July 3, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

If IPD is asked for, anonymized raw data can be shared

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
From March 2023 until March 2053

Locations